Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells.

Abstract:

:The mammalian target of rapamycin (mTOR) is a key kinase acting downstream of growth factor receptor PI3K and AKT signaling, leading to processes resulting in increased cell size and proliferation through translation control. Rapamycin, a specific inhibitor of mTOR, results predominately in G1 cell cycle arrest through translation control and occasionally, cell type-dependent apoptosis by an unknown mechanism. In this study, we investigated the effect and mechanism of action of rapamycin on non-small cell lung cancer (NSCLC) cell lines with p53 mutations. Cell proliferation was evaluated by modified MTT assay. The apoptotic effect of rapamycin was measured by caspase-3 activation and flow cytometric analysis of Annexin V binding. The expression of Bcl-2 and the release of cytochrome c from mitochondria were evaluated by western blotting. We found that rapamycin induced apoptosis in NSCLC cell lines with p53 mutations. Western blot analysis demonstrated that rapamycin downregulates the expression levels of Bcl-2, which leads to increased cytochrome c release from mitochondria and subsequent activation of caspase cascades. These findings suggest that rapamycin induces p53-independent apoptosis through downregulation of Bcl-2 and the mitochondrial pathway in NSCLC cell lines as a novel antitumor mechanism.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Miyake N,Chikumi H,Takata M,Nakamoto M,Igishi T,Shimizu E

doi

10.3892/or.2012.1855

subject

Has Abstract

pub_date

2012-09-01 00:00:00

pages

848-54

issue

3

eissn

1021-335X

issn

1791-2431

journal_volume

28

pub_type

杂志文章
  • Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.

    abstract::Cisplatin (CDDP)‑based combination chemotherapy is the standard for muscle‑invasive bladder cancer (MIBC). However, nearly all patients undergoing CDDP chemotherapy become refractory due to the development of CDDP resistance. Therefore, clarification of the mechanisms of CDDP resistance is urgently needed. The transcr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7039

    authors: Sekino Y,Sakamoto N,Ishikawa A,Honma R,Shigematsu Y,Hayashi T,Sentani K,Oue N,Teishima J,Matsubara A,Yasui W

    更新日期:2019-05-01 00:00:00

  • Differential proteomic analysis of HL60 cells treated with secalonic acid F reveals caspase 3-induced cleavage of Rho GDP dissociation inhibitor 2.

    abstract::Secalonic acid F (SAF) has been previously identified, however, little is known about its cytotoxic activity and related cytotoxic mechanism. The aim of this study was to evaluate the cytotoxic activity of SAF isolated from a deep sea originated fungus Penicillium sp. F11 in HL60 ce...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2062

    authors: Li N,Yi Z,Wang Y,Zhang Q,Zhong T,Qiu Y,Wu Z,Tang X

    更新日期:2012-12-01 00:00:00

  • Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.

    abstract::Kruppel-like factor 9 (KLF9), a transcription factor, is critical for the inhibition of growth and development of tumors, whereas its effects in pancreatic cancer remains unclear. The purpose of the present study was to investigate the expression and functional significance of KLF9 in vitro, by assessing the expressio...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6760

    authors: Zhong Z,Zhou F,Wang D,Wu M,Zhou W,Zou Y,Li J,Wu L,Yin X

    更新日期:2018-12-01 00:00:00

  • Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.

    abstract::Immature colon carcinoma transcript-1 (ICT1) is a newly identified oncogene, which regulates proliferation, cell cycle progression and apoptosis of cancer cells. However, the clinical significance, biological function and underlying mechanisms of ICT1 in hepatocellular carcinoma (HCC) remain poorly known. In the prese...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6046

    authors: Chang W,Yu Z,Tian M,Lin X

    更新日期:2017-12-01 00:00:00

  • Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review).

    abstract::The long-term effort in investigating chemical methods to eliminate only cancer cells has improved our knowledge and has led to the development of new drugs. The targets for cancer treatment may be large polymeric molecules such as DNA or microtubules as well as regulatory pathways for tumor development and cell survi...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.9.6.1257

    authors: Stathopoulos GP

    更新日期:2002-11-01 00:00:00

  • Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.

    abstract::The lipogenic enzyme fatty acid synthase (FAS) is differentially overexpressed and hyperactivated in a biologically aggressive subset of breast carcinomas and minimally in most normal adult tissues, rendering it an interesting target for anti-neoplastic therapy development. Current trends in the treatment of human bre...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Menendez JA,Colomer R,Lupu R

    更新日期:2004-08-01 00:00:00

  • Overall survival with and without laryngeal function preservation in 580 patients with hypopharyngeal squamous cell carcinoma.

    abstract::The aims of the present study were to review the experience of different surgical reconstruction methods for hypopharyngeal squamous cell carcinoma (HSCC) and compared the survival of patients with and without laryngeal function (LF) preservation. The clinical characteristics of 580 patients were retrospectively obtai...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4313

    authors: Zhou J,Li Y,Wei D,Qian Y,Li W,Liu D,Li G,Pan X,Lei D

    更新日期:2015-12-01 00:00:00

  • MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression.

    abstract::MicroRNA-374a (miR-374a) is involved in the progress of various types of cancer, and may indicate a poor prognosis. However, its role in esophageal cancer remains to be determined. In the present study, the role of miR-374a in esophageal cancers and cancer cell growth was examined using miR-374a overexpression and und...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4182

    authors: Wang Y,Xin H,Han Z,Sun H,Gao N,Yu H

    更新日期:2015-10-01 00:00:00

  • Possible predictive markers related to micro-metastasis in breast cancer patients.

    abstract::Despite significant advances in micro-metastasis detection methods, little is known about the relationship between micro-metastasis and primary tumors. The purpose of this study was to assess the ability of expression of the breast cancer-related markers, HER-2/neu, COX-2, VEGF and PDGF-B, as a predictor for micro-met...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zhu L,Loo WT,Cheng CW,Chow LW

    更新日期:2006-05-01 00:00:00

  • Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling.

    abstract::The clinical applications of Rhizoma paridis in traditional Chinese medicine are well known. However, the therapeutic potential of Rhizoma paridis and its active component such as Paris saponin I (polyphyllin D) and Paris saponin II (PSII) (formosanin C) in cancer treatments have not yet been fully explored. Recent st...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3836

    authors: Yang M,Zou J,Zhu H,Liu S,Wang H,Bai P,Xiao X

    更新日期:2015-05-01 00:00:00

  • Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.

    abstract::The ING1 gene is involved in the regulation of the cell cycle, senescence, and apoptosis and is a novel candidate tumor suppressor gene. ING2, another gene in the ING family, was identified and cloned. The functions of ING1 and ING2 largely depend on the activity of p53. To determine whether an alteration in these gen...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Okano T,Gemma A,Hosoya Y,Hosomi Y,Nara M,Kokubo Y,Yoshimura A,Shibuya M,Nagashima M,Harris CC,Kudoh S

    更新日期:2006-03-01 00:00:00

  • Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.

    abstract::The estrogen receptor (ER) expression and HER2 amplification are important factors in determining the prognosis and therapy of breast cancer. Interactions between the two signaling pathways for example resulted in ERalpha-dependent regulation of HER2 expression in breast cancer cells. In this study, we investigated to...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Lattrich C,Juhasz-Boess I,Ortmann O,Treeck O

    更新日期:2008-03-01 00:00:00

  • Evaluation of ERalpha, PR and ERbeta isoforms in neoadjuvant treated breast cancer.

    abstract::The actual predictive value of oestrogen receptor (ER) beta for treatment decisions in breast cancer is still unclear. Retrospective studies using preoperative systemic therapy (PST) revealed that chemotherapy but also endocrine therapy can lead to alterations in expression levels of ERalpha and progesterone receptor ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Wurster M,Ruoff A,Meisner C,Seeger H,Vogel U,Juhasz-Böss I,Solomayer E,Wallwiener D,Fehm T,Neubauer H

    更新日期:2010-09-01 00:00:00

  • Selected nitrostyrene compounds demonstrate potent activity in chronic lymphocytic leukaemia cells, including those with poor prognostic markers.

    abstract::The nitrostyrene scaffold was previously identified as a lead target structure for the development of effective compounds targeting Burkitt's lymphoma. The present study aimed to develop these compounds further in haematological malignancies, including chronic lymphocytic leukaemia (CLL). Cellular viability, flow cyto...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7068

    authors: Bright SA,Byrne AJ,Vandenberghe E,Browne PV,Mcelligott AM,Meegan MJ,Williams DC

    更新日期:2019-05-01 00:00:00

  • β2-adrenergic receptor activation promotes the proliferation of A549 lung cancer cells via the ERK1/2/CREB pathway.

    abstract::Lung cancer is one of the most common cancers worldwide and accounts for 28% of all cancer-related deaths. The expression of the β2‑adrenergic receptor (β2‑AR), one of the stress‑inducible receptors, has been reported to be closely correlated with malignant tumors. However, the role of β2‑AR activation in human lung e...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4966

    authors: Hu P,He J,Liu S,Wang M,Pan B,Zhang W

    更新日期:2016-09-01 00:00:00

  • Analysis of T-helper type 1 and 2 cells and T-cytotoxic type 1 and 2 cells of sentinel lymph nodes in breast cancer.

    abstract::The immune suppression of sentinel lymph node (SN) is directly influenced by primary tumors. It has been reported that the T-helper type 1 (Th1) to T-helper type 2 (Th2) ratio or T-cytotoxic type 1 (Tc1) to T-cytotoxic type 2 (Tc2) ratio of lymph node lymphocytes could be used to evaluate direct immunological circumst...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Ehi K,Ishigami S,Masamoto I,Uenosono Y,Natsugoe S,Arigami T,Arima H,Kijima Y,Yoshinaka H,Yanagita S,Kozono T,Funasako Y,Maruyama I,Aikou T

    更新日期:2008-03-01 00:00:00

  • Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast.

    abstract::Members of the Eph family of receptor tyrosine kinase have been implicated in cell-cell communication and tissue integrity during embryogenesis. We have previously demonstrated cell type specific and hormone dependent EphB4 expression in the mouse mammary parenchyma suggesting involvement in the homeostasis of this or...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Berclaz G,Flütsch B,Altermatt HJ,Rohrbach V,Djonov V,Ziemiecki A,Dreher E,Andres AC

    更新日期:2002-09-01 00:00:00

  • L‑Deprenyl exerts cytotoxicity towards acute myeloid leukemia through inhibition of mitochondrial respiration.

    abstract::The identification of large numbers of genetic mutations in immature myeloid cells has made it difficult to identify specific targets for acute myeloid leukemia (AML) therapy. Although current pharmacological targets for controlling cancer are focused on identifying genetic mutations, it is hard to develop the specifi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6753

    authors: Ryu I,Ryu MJ,Han J,Kim SJ,Lee MJ,Ju X,Yoo BH,Lee YL,Jang Y,Song IC,Chung W,Oh E,Heo JY,Kweon GR

    更新日期:2018-12-01 00:00:00

  • miR‑144‑3p regulates the resistance of lung cancer to cisplatin by targeting Nrf2.

    abstract::Chemotherapeutic drug resistance is correlated with treatment failure and poor prognosis among lung cancer patients. Numerous studies indicate the relevance of miRNAs in inducing certain drug resistance. In the course of the study, we unexpectedly found that miR‑144‑3p could regulate the cisplatin resistance of lung c...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6772

    authors: Yin Y,Liu H,Xu J,Shi D,Zhai L,Liu B,Wang L,Liu G,Qin J

    更新日期:2018-12-01 00:00:00

  • Chemotherapy-induced modification of microRNA expression in esophageal cancer.

    abstract::Neoadjuvant chemotherapy is often used in the treatment of advanced esophageal cancer. In this study, we determined the impact of chemotherapy on microRNA (miRNA) expression in esophageal cancer cells, and whether identified changes might have biological relevance. Two esophageal carcinoma cell lines (one adenocarcino...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1381

    authors: Hummel R,Wang T,Watson DI,Michael MZ,Van der Hoek M,Haier J,Hussey DJ

    更新日期:2011-10-01 00:00:00

  • Epimedium koreanum Nakai inhibits PMA-induced cancer cell migration and invasion by modulating NF-κB/MMP-9 signaling in monomorphic malignant human glioma cells.

    abstract::Previously, we showed that the herbal extract EYK (Epimedium koreanum Nakai) can regulate the immune response. Other studies showed that EYK has beneficial effects in human lung cancer, angiogenesis and Alzheimer's disease (AD). However, it remains unknown whether EYK can affect cancer cell migration and invasion in h...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6043

    authors: Lee W,Nam JH,Cho HJ,Lee JY,Cho WK,Kim Υ,We YM,Ma JY,Hoe HS

    更新日期:2017-12-01 00:00:00

  • TIPE2 inhibits GC via regulation of cell proliferation, apoptosis and inflammation.

    abstract::Gastric cancer (GC), a type of gastric mucosal epithelium disease caused by common malignant tumors, has become a major threat to human health and survival. Tumor necrosis factor‑α‑induced protein‑8 like‑2 (TIPE2) is a negative immune regulatory factor that is selectively expressed in immune organs, immune cells and v...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6576

    authors: Lin Z,Liu W,Xiao C,Fan Y,Zhuang G,Qi Z

    更新日期:2018-09-01 00:00:00

  • miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.

    abstract::Expression of miR-365 has been reported to be downregulated in hepatocellular carcinoma (HCC). However, the biological function and underlying mechanism of miR-365 in HCC growth and metastasis remain unclear. The aim of the present study was to explore the role of miR-365 in HCC progression. We found that miR-365 expr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5423

    authors: Liu Y,Zhang W,Liu S,Liu K,Ji B,Wang Y

    更新日期:2017-03-01 00:00:00

  • Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue.

    abstract::Vitamin K2 (VK2) has been shown to have a potent anti-tumor effect against several cancer types including hepatocellular carcinoma (HCC), but the mechanisms remain to be elucidated. Matrix metalloproteinase (MMP) plays an important role in the invasion and metastasis of cancer cells, but it is not known whether VK2 re...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000478

    authors: Ide Y,Zhang H,Hamajima H,Kawaguchi Y,Eguchi Y,Mizuta T,Yamamoto K,Fujimoto K,Ozaki I

    更新日期:2009-09-01 00:00:00

  • Oncogenic chromosomal translocations and human cancer (review).

    abstract::Chromosomal translocations are very common in human cancer. The molecular mechanisms of chromosomal translocations are complex and are not fully understood. Recent studies showed organization of genomes is higher-order in the nucleus and every chromosome or chromatin has its preferential position and territory. These ...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2013.2677

    authors: Zheng J

    更新日期:2013-11-01 00:00:00

  • MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.

    abstract::MicroRNAs (miRNAs) that negatively regulate gene expression play a key role in the development and progression of cancer. Aberrant expression of hsa-miR-187 (miR-187) has been reported in various malignancies. However, the function of miR-187 in tumor progression remains controversial and its role in non-small cell lu...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5548

    authors: Cai Y,Ruan J,Yao X,Zhao L,Wang B

    更新日期:2017-05-01 00:00:00

  • Clinical significance of altered S100A2 expression in gastric cancer.

    abstract::The S100A2 gene has been reported to be a putative tumor‑suppressor gene. Nevertheless, overexpression of S100A2 has been found in certain types of cancer. This study investigated S100A2 expression in tissue specimens of gastritis, intestinal metaplasia, adenomatous dysplasia and ga...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2236

    authors: Zhao Y,Zhang TB,Wang Q

    更新日期:2013-04-01 00:00:00

  • Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells.

    abstract::To study the role of the chemokine receptor CCR7 in the metastatic process, a murine CCR7 gene was transduced in two mammary cancer cell lines with different origins and molecular features; TS/A, derived from a spontaneous mammary cancer of BALB/c strain, and N202.1A, derived from a HER-2/neu transgenic mammary cancer...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Croci S,Nicoletti G,Landuzzi L,Palladini A,Chiarini F,Nanni P,Lollini PL,De Giovanni C

    更新日期:2007-08-01 00:00:00

  • Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.

    abstract::Glioblastoma multiforme (GBM) is one of the most malignant and aggressive tumors, and has a very poor prognosis with a mean survival time of <2 years, despite intensive treatment using chemo-radiation. Therefore, novel therapeutic approaches including immunotherapy have been developed against GBM. For the purpose of i...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3049

    authors: Akiyama Y,Komiyama M,Miyata H,Yagoto M,Ashizawa T,Iizuka A,Oshita C,Kume A,Nogami M,Ito I,Watanabe R,Sugino T,Mitsuya K,Hayashi N,Nakasu Y,Yamaguchi K

    更新日期:2014-04-01 00:00:00

  • Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.

    abstract::Improvements in detection, treatment and prognosis for patients with non-small cell lung cancer (NSCLC) depend on the molecular understanding of tumor development and progression. Using Affymetrix GeneChips comprising 59,620 elements, we determined the gene expression profiles of 89 NSCLC and 15 normal lung samples. W...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Hofmann HS,Bartling B,Simm A,Murray R,Aziz N,Hansen G,Silber RE,Burdach S

    更新日期:2006-09-01 00:00:00